SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-15-003213
Filing Date
2015-11-09
Accepted
2015-11-09 14:00:38
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_093015.htm 10-Q 486911
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 8603
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 8403
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 3838
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 3853
  Complete submission text file 0001387131-15-003213.txt   2713052

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT admp-20150930.xml EX-101.INS 494193
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20150930.xsd EX-101.SCH 32650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20150930_cal.xml EX-101.CAL 40735
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20150930_def.xml EX-101.DEF 109313
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20150930_lab.xml EX-101.LAB 227259
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20150930_pre.xml EX-101.PRE 174469
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 151215049
SIC: 2834 Pharmaceutical Preparations